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Abstract 
The hepatoprotective study of Raphanus sativus and Lepidium 
sativum seeds extracts was performed on rats in which liver damage was 
induced by carbon tetrachloride (CCL4). 
 The oral administration of the methanolic and water extracts of 
Raphanus sativus (200 and 400 mg/kg) significantly reduced the CCL4 
induced hepatotoxicity as indicated by inhibition of increased serum 
AST, ALT and ALP activities and bilirubin concentration.  
The effect of methanolic and ethanolic extracts of Lepidium 
sativum (200and 400mg/kg) on liver damaged produced by CCL4 was 
less evident as reflected by measurement of serum AST, ALT and ALP 
activities and bilirubin concentration and histopathological changes. 
 Toxicity study of both plants revealed that Raphanus sativus had 
no adverse effect on liver while Lepidium sativum caused mild 
vacuolation of hepatocytes. 
 These results indicate that Raphanus sativus is more effective in 
the protection against CCL4-induced liver damage than Lepidium 
sativum. 
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  ﻣﻠﺨﺺ اﻹﻃﺮوﺣﺔ 
ﻦ ﻣﻦ ﺑﺬور ﻓﻲ هﺬﻩ اﻹﻃﺮوﺣﺔ ﺗﻤﺖ دراﺳﺔ إﻣﻜﺎﻧﻴﺔ ﺣﻤﺎﻳﺔ اﻟﻜﺒﺪ ﺑﻮاﺳﻄﺔ ﻣﺴﺘﺨﻠﺼﺎت ﻷﺛﻨﻴ  
  .  اﻟﺘﻲ ﻳﺴﺘﺨﺪﻣﻬﺎ اﻟﻌﺸﺎﺑﻴﻦ ﻟﻌﻼج اﻟﻴﺮﻗﺎن،اﻟﻔﺠﻞ واﻟﺮﺷﺎد اﻟﻨﺒﺎﺗﺎت اﻟﺴﻮداﻧﻴﺔ
 ﻓﻲ  إﺣﺪاث ﺗﻌﻄﻴﻞ ﻟﻠﻜﺒﺪ ﺑﻮاﺳﻄﺔ ﺣﻘﻨﻬﺎ اﻟﺘﻰ ﺗﻢ ﻓﻴﻬﺎ اﻟﺪراﺳﺔ ﻓﻲ اﻟﺠﺮزان اﻟﺒﻴﻀﺎءأﺟﺮﻳﺖ  
  . أﻳﺎم01 ﻟﻤﺪة آﺠﻢ ﻳﻮﻣﻴﺎ/ ﻣﻞ2.0ﺑﻤﺎدة راﺑﻊ آﻠﻮرﻳﺪ اﻟﻜﺮﺑﻮن ﺑﺠﺮﻋﺔ اﻟﺒﺮﻳﺘﻮن 
 004آﺠﻢ و/ ﻣﻠﺠﻢ 002ﻤﻴﺜﺎﻧﻮل ﻣﻦ ﺑﺬور اﻟﻔﺠﻞ ﺑﺠﺮﻋﺘﻲ ﻋﻨﺪ إﻋﻄﺎء ﻣﺴﺘﺨﻠﺺ اﻟ  
 ﻓﻲ اﻟﺒﻠﻮرﺑﻴﻦﺗﺮآﻴﺰ  و)PA ,TLA ,TSA( إﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ ﻧﺸﺎطآﺠﻢ، ﺗﻢ ﻣﻼﺣﻈﺔ اﻧﺨﻔﺎض/ﻣﻠﺠﻢ
  .ﻣﻘﺎرﻧﺔ ﻣﻊ اﻟﻤﺠﻤﻮﻋﺔ اﻟﻤﺤﻘﻮﻧﺔ ﺑﺮاﺑﻊ آﻠﻮرﻳﺪ اﻟﻜﺮﺑﻮن ﻓﻘﻂاﻟﻤﺼﻞ 
ﺣﻈﺔ آﺠﻢ، ﺗﻢ ﻣﻼ/ ﻣﻠﺠﻢ002أﻣﺎ ﻋﻨﺪ إﻋﻄﺎء اﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻲ ﻟﺒﺬور اﻟﻔﺠﻞ ﺑﺠﺮﻋﺔ   
آﺠﻢ / ﻣﻠﺠﻢ004 ﺟﺮﻋﺔ ﺎ، أﻣ ﻓﻲ اﻟﻤﺼﻞ اﻟﺒﻠﻮرﺑﻴﻦ ﺗﺮآﻴﺰإﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ وارﺗﻔﺎع ﻧﺸﺎط اﻧﺨﻔﺎض
  . ﻓﻲ اﻟﻤﺼﻞاﻟﺒﻠﻮرﺑﻴﻦﺗﺮآﻴﺰ  إﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ وأﺣﺪﺛﺖ اﻧﺨﻔﺎض ﻓﻲ ﻧﺸﺎط
  ﻧﺸﺎطآﺠﻢ اﻧﺨﻔﺾ/ ﻣﻠﺠﻢ002ﻋﻨﺪ إﻋﻄﺎء ﻣﺴﺘﺨﻠﺺ اﻟﻤﻴﺜﺎﻧﻮل ﻟﺒﺬور اﻟﺮﺷﺎد ﺑﺠﺮﻋﺔ   
 ﻓﻲ  اﻧﺨﻔﺎضاﺣﺪﺛﺖآﺠﻢ / ﻣﻠﺠﻢ004رﺑﻴﻦ، أﻣﺎ ﺟﺮﻋﺔ  اﻟﺒﻠﻮارﺗﻔﻊ ﺗﺮآﻴﺰﺑﻌﺾ إﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ و
  . اﻟﺒﻠﻮرﺑﻴﻦ ﻓﻲ ﺗﺮآﻴﺰ إﻧﺰﻳﻤﺎت اﻟﻜﺒﺪ وارﺗﻔﺎعﻧﺸﺎط
 004آﺠﻢ و/ ﻣﻠﺠﻢ002أﻣﺎ ﻋﻨﺪ إﻋﻄﺎء ﻣﺴﺘﺨﻠﺺ اﻹﻳﺜﺎﻧﻮل ﻟﺒﺬور اﻟﺮﺷﺎد ﺑﺠﺮﻋﺘﻲ   
 . ﻓﻲ اﻟﻤﺼﻞ اﻟﺒﻠﻮرﺑﻴﻦارﺗﻔﻊ ﺗﺮآﻴﺰ اﻟﻜﺒﺪ وتﺎ إﻧﺰﻳﻤ ﻧﺸﺎطآﺠﻢ اﻧﺨﻔﺾ/ﻣﻠﺠﻢ
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Introduction 
 
 Liver diseases remain a sensuous problem facing almost all 
societies world wide. However, conventional drugs used in pharmaco- 
therapy is conceived to provide substantial contributions to solve this 
problem  in the treatment of liver diseases but are some times inadequate 
and can have serious adverse effects. 
 The use of natural remedies for the treatment of liver diseases has 
been reported a long history, starting with the Ayurvedhic treatment, and 
extending to the Chinese, Indian and European traditional medicines. The 
21st century has seen a paradigm shift towards therapeutic evaluation of 
herbal products in liver diseases by carefully synergizing the strengths of 
the traditional medicine with the modern concept of evidence-based 
medicinal evaluation, standardization of herbal products and placebo 
controlled clinical trials for supporting clinical efficacy. 
 The liver damage can be caused by free radicals through the 
mechanism of covalent binding all lipid per oxidation. The antioxidant 
agents of natural origin i.e. medicinal plants can protect the body from 
free radicals 
 Now, it is time, therefore, to search for treatment that stems from 
natural substances for curing liver disease so as to replace currently used 
drugs of doubtful efficacy and safety. Numerous medicinal plants and 
their formulations are used for liver disorder in ethanomedical practices 
as well as traditional medicine in Sudan. This will contribute to the 
improvement of economy of the country by involving the industrial use 
of natural drugs and saving the foreign exchange presently being spent on 
the import of different synthetic drugs. 
  The present study was carried out to confirm the folkloric uses of 
two plants Raphanus sativus and Lepidium sativum as hepatoprotective 
agents. 
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CHAPTER ONE  
LITERATURE REVIEW 
1. 1. The Liver 
The liver is the largest gland in the body which performs many 
functions essential for life, e.g. the production of bile that plays role in 
protein, carbohydrate and fat metabolism. It is located in the most cranial 
part of the abdomen, it lies to the right side in all species immediately 
behind the diaphragm. It is not so very asymmetrical in the dog. The 
proportion to the right and left of the mediam plane being about 3:2 in 
most species. The liver is grossly divided into lobes by a series of 
fissures.  
The metabolic functions of the liver explain the wide interspecific 
variation in size, with  average of 3 to 4 percent of body weight in 
carnivores, 2 to 3 percent in omnivores and 1 to 1.5 percent in herbivores. 
It is substantially heavier in the youngs than in the adult and often shows 
a considerable atrophy in old age. 
The liver is surrounded by peritoneum except for a relatively small 
areas at the “porta” (hilus), the fossa for the gallbladder, and at the origin 
of certain peritoneal reflections. It receives a very generous blood supply 
through the hepatic artery, a branch of the celiac artery, and the protal 
vein. The relative importance of these two supplies varies between 
species. The branches of the hepatic artery that actually enter the liver are 
effectively end-arteries. However, there is provision for collateral 
circulation outside the liver, between the hepatic artery and the other 
branches of the celiac artery that supply the stomach and duodenum. 
The intrahepatic arteries are divided in company with branches of 
the portal vein and tributaries of the hepatic duct. They supply the 
connective tissue structures in route to the hepatic sinusoids into which 
they eventually discharge. The portal vein is formed by the union of 
tributaries draining the digestive tract, pancreas and spleen. It is 
connected to systemic veins in the cardioesophageal and rectoanal 
regions at the extremities of its territory. These connections provide 
alternative outlets for portal blood when the flow through the liver is 
obstructed or impaired. All blood delivered to the liver is collected by a 
single set of veins of which the central veins of the hepatic lobules are the 
smallest radicles. These eventually form the large hepatic veins that open 
into the caudal venacava. The circulation through the liver possesses 
numerous anastomses-interarterial, intervenous, and arteriovenous which 
are controlled by various sphincter mechanisms. 
The hepatic duct system begins with microscopic canaliculi within 
the lobules. These open into larger ductules which by successive unions 
with the connective tissue between the lobules ultimately form a few 
large hepatic ducts. Before, or shortly after, leaving the liver at the porta 
these combine in a single trunk that runs to the duodenum. A side 
tortuous branch that arises from the common trunk is the gall bladder 
cystic duct and  the part of the common trunk that is distal to the origin of 
the cystic duct is known as the bile duct (ductus choledochus). There may 
be variation in the duct system among species, some hepatic ducts may 
enter the gall bladder directly, other may join the main outlet distal to 
cystic duct. The gall bladder not only stores the bile but also concentrates 
it by absorption through its folded mucosa. The gall bladder is not 
essential and it is lacking in the horse, rats, and other species. They 
compensate by enlargement of the duct system. 
 The liver receives sympathetic and parasympathetic nerves from 
periarterial plexuses and the vagal trunks, respectively. The muscle of the 
bladder wall and ducts, including the sphincter at the entrance to the 
duodenum, is supplied by parasympathetic nerves. Pain arising from the 
duct system, common in man, is abolished by section of the (sympathetic) 
splanchnic nerves (Dyce et al, 1987 ). 
1.1.1. Clinical Examination of the Liver 
 General clinical examination of the liver may suggest primary or 
secondary diseases.Physical examination of the liver may be coupled with 
biochemical tests, biopsy and occasionally radiographic examination.  
 The position of the liver in most species of animals makes the 
physical examination to be of limited value. In cattle, dogs and cats, gross 
enlargement of the liver (hepatomegaly) causes the right or ventral border 
to project beyond the costal arch or xiphoid cartilage, and the edge is 
thickened and rounded. Enlargement of the liver occurs as the result of 
severe congestion, plant poisoning such as seneciosis, multiple 
abscessation, metastatic neoplasia, and in occasional cases of hydatidosis. 
In acute diffuse hepatitis, the increase in the liver size is not sufficient to 
be detected by physical examination.  
 By percussion it is possible to have some ideas about the dull areas 
in the liver, but it is unlikely be recognize hepatic enlargement regulary in 
this way. However, strong percussion or deep palpation of the liver aids 
in recognizing the presence and severity of hepatic pain (Kelly, 1984). 
1.1.2. Clinical Signs of Hepatic Diseases 
 The main sign of liver damage is jaundice. Secretion of bile is one 
of the most important functions of the liver. Bile is composed of bile 
salts, which are derived from the metabolism of cholesterol, bile pigment, 
excretory products derived from the catabolism of haemoglobin liberated 
from effete erythrocytes, alkaline phosphatase, water and various lipids 
including cholesterol and lecithin. Bile salts are involved in the digestion 
and absorption of fats; about 90 percent recycles from the small intestine 
back to the liver and is resecreted in the bile. The initially formed free 
bilirubin, is conjugated in the liver cells with glucuronic acid forming 
bilirubin glucuronide. In ruminant species, bilirubin is rapiddly oxidized 
to biliverdin which gives the bile it’s characteristically green colour. 
When the liver is damaged, the quantities of bile pigment in blood, urine, 
faeces and body tissues will change as the result of deranged secretion 
and excretion. Jaundice, arising from the retention of bilirubin in elastic 
tissue, is manifested clinically by orange-yellow discolouration of 
especially the sclera,  submucosal tissues, unpigmented skin and other 
body structures. 
 Jaundice occurs not only in diseases of liver and biliary system, but 
also in other diseases. Also it may not develop even when the liver is 
extensively involved as in acute hepatitis. The intensity of tissue staining 
is much more pronounced with conjugated than with uncojugated 
bilirubin. Jaundice has been classified in many ways but for clinical 
purposes the basic differentiation is between jaundice with and without 
biliary obstruction.  
 In mechnical or obstructive janudice arising from obstruction of the 
bile ducts, the discoloured tissues are greenish- yellow, and when biliary 
obstruction is complete, bile pigments are absent from the faeces, the 
serum level of conjugated bilirubin become markedly elevated so that 
large amounts are excreted in the urine which is free of urobilinogen 
because no bile pigment is available in the intestine for its formation. 
Jaundice caused by excessive intravascular haemolysis (Haemolytic or 
over production) results in an abnormally large quantity of bile being 
produced. This is very common in animals and maybe caused by bacterial 
toxins (Bacillaryhaemoglobinuria , Leptospirosis), Protozoa (Babesiosis, 
Anaplasmosis, erythrozoonosis), viruses (equine infectious anaemia), in- 
organic and orgnic poisons (chronic copper and selenium in sheep, 
phenothiazine in horses), vegetable poisons (rape, kale, and other 
cruciferous plants), snake venoms, and immunological reactions (iso- 
immunization haemolytic aneamia of foals, piglets and puppies).  
 Jaundice due to hepatic cell degeneration occurs when the 
parenchyma of the liver has been damaged to a sufficient degree to 
interfere with the normal formation and elimination of bile. The cause 
may be any disease associated with acute or chronic diffuse hepatitis. 
Other clinical signs observed in animals with diffuse hepatic disease, 
include the nervous signs, oedema and emaciation, deranged intestinal 
function, haemorrhagic diathesis and abdominal pain. The nervous signs 
maybe associated with hypoglycaemia, accumulation of excess amino 
acids, ammonia, or acetylcholine, this may be due to failure of the normal 
hepatic detoxification mechanisms, and the liberation of toxic break down 
products derived from the liver parenchyma. The oedema is usually most 
marked in the intermandibular space; in obstruction to the portal 
circulation, but in hepatic fibrosis, oedma is limited to the peritoneal 
cavity.  
 Abdominal pain in liver diseases may be due to tension of the 
capsule due to increase in the size of the liver or lesions involving the 
capsule itself. Clinically, pain of hepatic origin causes arching of the 
back, disinclination to move, tenseness of the abdominal wall, and pain 
on deep palpation over the hepatic area (Kelly, 1984). 
1.1.3. Liver Function Tests  
 Liver derangement in disease can be assessed properly by testing 
hepatic functions. The tests can be classified into five groups namely, 
those that measure secretory and excretory functions; those that measure 
the metabolic activity of the liver; those which measure protein, lipid and 
carbohydrate metabolism; those which test detoxification mechanisms; 
and the serum enzyme tests. The secretory and excretory functions are 
measured by alteration in the quantities of bile pigment in the blood, 
urine and faeces, beside measuring the excretory rate of bile pigment. The 
serum enzyme activity has been used for assessment of the integrity of 
hepatic cells. The activity of certain serum enzymes can be as a result of:- 
(a) Elevation due to disruption of heptic parenchymal cells because 
of necrosis, or increased membrane permeability which permits 
leakage of  cytoplasmic enzymes into the hepatic sinusoids e.g. 
alanine aminotransferase (ALT) which is of no value in 
assessing liver function in ruminants because it occurs in very 
low levels in hepatocytes but in the dog, cat and primates, this 
enzyme exists in high concentration in hepatic cells and might 
be regarded as being a good indicator of liver cell injury , 
aspartate aminotranferase (AST), isocitric dehydrogenase (ICD) 
and lactic dehydrogenase (LDH) occur in tissues other than the 
liver, while measurement of activity of arginase, soribital 
dehdrogenase (SDH), glutamate dehydrogenase (GDH) and 
ornithine carbamyl transferase (OCT) are of considerable value 
in assessing hepatic cell function. 
(b) Elevation because of lack of biliary excretion in obstructive 
jaundice, e. g. Alkaline phoshatase (ALP).  
(c) Decrease due to impaired synthesis by the liver, e.g. 
cholinesterase. 
 The plasma concentration of gamma glutamyl transpeptidase (CGT) is of 
value in detecting damage affecting the biliary epithelium. Bilirubin, the  
major bile pigment in the serum of domestic animals, exists as protein- 
bound in the plasma, and a conjungated bilirubin glucuronide. Usually, if 
more than 25% of the total serum bilirubin is conjugated, hepatocelluar 
damage might be suspected, whereas if it is greater than 30% , intra- or 
extrahepatic bilary stasis could be suspected. When the total serum 
bilirubin value is elevated, and more than 50% is conjugated, liver cell 
damage has probably occurred. Free bilirubin suggests a prehepatic or 
haemolytic disease.  
 In horses, the signifcance of elevated serum bilirubin is of no value 
because unconjugated bilirubin are raised in a variety of disease unrelated 
to primary liver disease. Also in fasting horses, a rapid rise up to 8 fold in 
serum bilirubin in 2-4 days can occur. In dogs, bile metabolism follows 
more closely the pattern in man (Kelly, 1984).  
1.1.4. Diseases of the Liver 
 Hepatic diseases can be diffuse or focal according to their extent. 
The causes of hepatitis include microbial infectious, toxic substances, 
parasitic and nutritional agents. The most common focal diseases of the 
liver are hepatic abscess, neoplasia and parasitic infestation. Unless 
extensive, localized lesions do not cause clinical signs. The main clinical 
signs suggesting the existence of hepatitis are anorexia, marked 
depression, muscular weakness, jaundice, excitement, vomition in dogs 
and cats, somnolence, recumbency, convulsions and coma in the terminal 
stages. Jaundice and oedema are variable signs. Local diseases of the 
liver require surgical or medical treatment depending upon the cause. 
Hepatic fibrosis is considered to be the final stage in hepatitis and 
treatment is not usually under taken (Blood et al, 1997).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2. Carbon tetrachloride  
 Drug and other chemicals are usually metabolized in the liver by 
the drug- metabolizing enzymes. The metabolites some times bind with 
cellular macromolecules and injure the cell directly or serve as new 
antigens to create immunologic injury (Schaffner ,et al 1975). 
 Carbon tetrachloride although used extensively as an 
anthelminthic it  frequently causes fatalities, particularly in ruminants.  It 
is slowly absorbed from the alimentary tract and a minimum non- toxic 
amount passes into tissues. Absorption of large amounts of the drug may 
lead to narcosis. Carbon tetrachloride may appear in the milk of lactating 
cows and produce a slight taint. (Setchell and Little johns, 1963).  
Accidental administration directly into the respiratory tract or inhalation 
of vapour of CCL4 may cause anaesthetic depression of the central 
nervous system and immediate pulmonary, and circulatory collapse. 
Death may occur within 24 hours of the dosing or after 2-7 days post-
dosing due to hepatic and renal insufficiency. 
 Carbon tetrachloride accidentally administered in excessive 
quantities may cause death but fatalities  more commonly occur in sheep 
when given standard doses and in cattle when dosed per os, instead of 
injection. A dose of 2 ml per animal to kill adult Fasciola hepatica or 1 
ml/ 10 kg body weight against immature forms has been widely used but 
in some circumstances these doses can be highly toxic to sheep. Doses as 
low as 0.5 ml/ 10 kg body weight and 1ml/10kg body weight cause liver 
damage in calves and apparent clinical effects in goats respectively 
(Blood et al, 1997). 
Carbon tetrachloride is metabolized by cytochrome P450 to an 
active trichloromethyl radical that triggers a chain of lipid peroxidation. 
These changes lead to cell injury, and if chronic lead to excessive 
deposition of collagen in liver, hence fibrosis. Carbon tetrachloride 
decreased hepatic glutathione level and increased glutathione- s- 
transferase content . This also causes a prominent collagen deposition in 
liver which is supported by the increased hepatic MRNA (Lee et al, 
2003). 
Halim et al, (1997) found out that carbon tetrachloride is an 
antioxidant that induced liver damage mainly necrosis and fibrosis.  
 Gallagher (1961) reported that the toxicity of carbon tetrachloride 
may be  due to its fat solvent action which destroys the selective 
permeability of cell membrane and allows the  escape of certain essential 
substances such as the pyridine nucleotide coenzymes. 
Rats exposed to 0.2 ml/kg of Carbon tetrachloride showed acute 
liver damage such as fatty change, ballooning degeneration, necrosis and 
inflammatory infiltration of lymphocytes around the central veins and 
caused increased plasma aspartate transferase (AST) and alanine 
transferase (ALT) activities (Valcheva et al, 2004). 
 Schiaffonati (1997) reported that CCl4 induced liver cell necrosis 
followed by regeneration, caused by free radical damage which might 
partly due to oxidative stress and subsequent formation of reactive 
oxygen intermediates. 
Carbon tetrachloride is a classical per central hepatotoxicant; 
however, precise details of its mechanism of action remain unknown. It 
was speculated that kupffer cells participate in this mechanism and high 
activity of aspartate aminotransferase (AST) is indicative of parenchymal 
cell damage (Edwards et al, 1993 ). 
 William (2002) believes that in liver damage, the serum enzyme 
activity particularly ALT, is raised .  
Luckey ,et al (2001) reported that kupffer cells are involved in the 
pathogenesis of chemically mediated liver injury through release of 
biologically active mediators that promote the pathogenic process. This is 
illustrated by clear specific biochemical and molecular changes to the 
exposed kupffer cells . 
Free radicals have been implicated in the pathogenesis of alcohol- 
induced liver injury in humans and carbon tetrachloride induced liver 
injury in rats ,the most extensively studied aspect of free radical induced 
liver injury is lipid peroxidation. It has been found that free radicals can 
cause oxidative damage to cellular proteins and alter cellular function 
(Sundari  et al, 1997 ). 
Salminen et al, (1997) reported that CCL4 induced an appropriate 
model of hepatic cirrhosis. 
Rikans et al  (1984) found that 24 hr after intraperitoneal 
administration of carbon tetrachloride at a dose rate of 0.2ml/kg in male 
rats, caused hepatotoxicity but serum alanine aminotransferase activity 
was unchanged or slightly diminished. 
 
 
 
 
 
 
 
 
 
 
1.3. Hepatoprotective Plants   
 The liver, the principal organ of metabolism and excretion, is 
subjected to a number of pathological changes, therefore, it is not 
surprising that it developed a considerable interest in the examination of 
those numerous world wide traditional plant remedies which are used for 
treatment. In recent years in vivo and in vitro test models have been 
developed for the evaluation of plants for their antihepatoxic activities. 
These systems measure the ability of the plant extract to prevent or cure 
liver toxicity in rats or mice induced by various hepatotoxins (Evans, 
2002) 
 Botanicals have been used traditionally by herbalists and 
indigenous healers worldwide for the prevention and treatment of liver 
disease.  Clinical research in this century has confirmed the efficacy of 
several plants in the treatment of liver disease (Luper, 1998 ). 
          In the Sudan, EL-Kamali and Khalid (1998) reported that , a 
decoction prepared from the bulb of Allium cepa is used to treat  
constipation , the bulb of Allium sativum is eaten to relieve fever, the 
powder of the herb Artemisa herba-alba (Sheeh) is administered as an 
antispasmodic , a decoction from the seed of Ocimum basilicum (Reihan) 
is used to treat jaundice. The decoction of the rhizome of Zingiber 
officinale (Zenjabeel) is mixed with milk to treat cough. They also 
reported that , Trigonella foenum graecum (Hilba) seeds swallowed with 
water to treat stomach disorders and dysentery , the powder of the seeds 
is used externally as poultice to treat boils , abscesses and carbuncles. The 
decoction from the seeds of Hilba is used as an antispasmodic, in 
treatment of malaria, hypertension and kidney disorder.  
 The water extract of the fruit of Balanites aegyptiaca (Hegleeg) is 
used as purgative and anthelmentic (ELghazali et al, 1987 ).  
 These authors also reported that, the water extract of Aristolochia 
bracteolata (Um glaagel) is used for abdominal pain and scorpion bites, 
the roots of Cissus quadrangularis (Sala,ala), is used against scorpion 
bite, the whole plant is taken for stomach pains and as poultice for joint 
pains, Tamarindus indica (Aradeeb) is used as laxative, and febrifuge and 
for malaria treatment. The water extract of the whole plant, 
Acanthospermum hispidum (Hourab ELhawsa) is used for bilharzias 
whereas the water extract of the roots are taken for headache.  
 Cucurbita pepo (Pumpkin) and Citrullus vulgaris (Water melon) 
seeds is used experimentally against Railletina tetragona infection in 
chicks (Mohamed 1995). 
 Galal et al, (1991) reported that, Albizzia anthelmintica (Girf EL 
Dood )is very active against Hymenolepis diminuta infection in albino 
rats.  
 Artemisia herbalba is encountered in eastern and western Sudan 
and has been found to have anthelminitic activity against experimental 
Haemonchus contortus infection in Nubian goats (Idris et al, 1982 ).  
 Balanites aegyptiaca tree is widely distributed and indigenous to 
Sudan .The fruit, bark and other parts of  Balanites aegyptiaca tree 
possess properties lethal to molluss, bilharzial miracidia and cercariae of 
animal trematodes. The fruit “Laloube” of Balanites aegyptiaca is used as 
purgative, remedy for liver and spleen conditions and have 
hepatoprotective effect against carbon tetrachloride (Raja, 2002). 
 The author also claimed that Solanum nigrum (Enab ELdib) 
spreads in Sudan. The plant is used in treatment of fever, diarrhea, eye 
diseases and has hepatoprotective effect against carbon tetrachloride.   
 Scientific research has uncovered the mechanisms by which some 
plants afford their therapeutic effects. Silybum marianum (Milk thistle) 
has been shown to have clinical applications in the treatment of various 
hepatic problems via its antioxidative, anti-lipid peroxidative, antifibrotic, 
anti-inflamatory, immunomodulating and liver regenerating effect and  
Picrorhiza kurroa appeared to have similar applications and mechanisms 
of action  to Silybum (Luper, 1998) 
 Yadav and Dixit (2003) reported that juice of the fresh leaves of 
Kolanchoe Pinnatepers is used very effectively for the treatment of 
jaundice in folk medicine . The juice and ethanolic extract of the leaves 
were studied in rats against CCL4 -induced hepatoxicity and were found 
to be  effective as hepatoprotectives.  
  Hepatoprotective effects of leaf extracts of Glycosmis 
pentaphylla was studied on CCL4 -induced hepatic injury in albino rats 
by Mitra and Sur,(1997). Who found that recovery of hepatic tissue was 
evidenced by activities of serum ALT,AST and ALP and total bilirubin 
concentration and microscopic tissue changes. 
 Also significant hepatoprotective effect was obtained against 
CCL4 –induced liver damage, by oral administration of Helminthostachys 
zeylanica methanolic extract (Suja et al, 2004).     
 Bhandarkar, and Khan (2004) reported that significant 
hepatoprotective effect was obtained against carbon tetrachloride- 
induced hepatic damage in albino rats by oral administration of various 
doses of flower extracts of Nymphaea stellata for 10 days. 
 Amalkadi ghrita (AG), a polyherbal formulation, was evaluated for 
its hepatoprotective activity against carbon tetrachloride –induced hepatic 
damage in rats. The hepatoprotective activity of (AG) was evaluated by 
measuring levels of serum marker enzymes like serum glutamate 
oxaloacetate transaminase (SGOT), alkaline phosphatase (ALP) and total 
bilirubin.This was supported by histopathology (Achlya et al, 2004 ). 
          The aqueous extract of Abutilon indicum was tested for 
hepatoprotective activity  against carbontetrachloride  and paracetamol – 
induced  hepatotoxicity in rats. A. indicum exhibited significant 
hepatoprtective activity by reducing  carbon tetrachloride induced 
changes in bio-chemical parameters (Porchezhian and Ansari, 2005).  
        Also hepatoprotective efficacy of Kamilari a polyherbal preparation 
was studied in carbon tetrachloride -induced liver dysfunction in albino 
rats by determining different biochemical parameters in serum and tissues 
(Rajesh et al,2004). 
          Azadirachta indica , a plant used widely in Ayurveda , has been 
reported to have anti-inflammatory, immunomodulatory and adaptogenic 
properties beside its hepatoprotective effect (Yanpallewar et al, 2003) . 
 Janbaz et al (2002) found that Rutin a well known flavonoid had 
protective effect against paracetamol - and carbon tetrachloride - induced 
hepatic damage . Pre-treatment of rodents with rutin reduced mortality 
rate of paracetamol and prevent the CCL4- induced increase in serum 
enzymes . 
 Hepatoprotective effect of the boiled and non-boiled aqueous 
extracts of Pistacia lentiscus , Phillyrea latifolia and Nicotiana glauca 
that are alleged to effectiveness in the treatment of jaundice in Jordanian 
folk medicine ,was evaluated  in vivo using carbon tetrachloride 
intoxicated rats as an experimental model. Plants extracts were 
administrated orally at a dose of 4 ml /kg body weight. The effect of non-
boiled aqueous extract was more pronounced than that of the boiled 
extract (Janakat et al, 2002). 
 Ethanolic extract of seven plants used against CCL4 -induced 
hepatoxicity in Turkish folk medicine were considered to be 
hepatoprotective. These plants are Carduns acanthoides, C. nutans, 
Cichorium intybus , Fumaria asepalae , F. vailantii , Gentiana olivieri 
and Plantago lanceolatl (Aktay et al, 2000). 
 In Unan, hepatoprotective effect was obtained against paracetamol 
and ethyl alcohol - induced liver damage by aqueous and ethanolic 
extract of leaves of Cassia occidentalis commonly known as “kasondi” 
(Jafri et al, 1999). 
 Sharma et al (1989) reported that alcoholic extract of whole plant, 
Wedelia calendulacea exhibited protective activity against carbon 
tetrachloride -induced liver injury.  
 Significant hepatoprotective effects were recorded for two plants 
namely Crepis rueppellii and Anisotes trisulcus, the traditional medicinal 
plants in Yemen , after carbon tetrachloride -induced hepatitis in rats 
(Fleurentin et al, 1986).  
 
1.4. Plants Used in this Study 
 The two plants belongs to the family Cruciferae,(Brassicaces) 
which is known as wall flower, taking their name from the cross-like 
arrangement of the four petals. The family includes many important 
forage crops (Clarke and Myre 1967). 
 The plant Raphanus sativus, the common name is Radish and the 
Arabic name is Alfgel, is very tolerant to environment, vegetative stage 
appears to have little response to a wide range of day length or 
temperature. The plant is annual, with swollen root, the tissue of which 
may be white, red or pink, leaf up to 10 in long, with lobed margins. 
White-rooted cultivars flower at low elevations; the red-rooted cultivars 
only flower at elevation over 3000 ft. White-rooted selections are more 
pungent than the red (Tindall, 1968). 
 Raphphanus sativus is cultivated every where. The seed pods as 
well as the roots are eaten. The seeds yield an oil and are used in native 
medicine fore their diuretic and laxative properties (Broun and Massey 
1929). 
 Kirtikar et al, (1987) reported that the Raphanus sativus has a hot, 
sharp, bitter taste. It has been found to be stomachic, binding and 
anthelmintic and useful in the diseases of heart. Raphanus sativus has 
been used in inflammation, hiccough, leprosy and cholera. The seeds 
have been used as carminative, tonic, peptic and corrective while seeds 
and leaves are diuretic, laxative and lithontriptic. All parts of this plant 
have been found to be effective in the cases of gravel and urinary tract 
diseases.  
 Raphanus sativus has been reported to possess anti-inflammatory, 
anti-fungal, anti-viral and anti-tumor activities(Fant et al, 1998 ; Terras et 
al ,1993). 
  The hepatoprotective study of Raphanus sativus fruit powder, it’s 
aqueous and ethanolic extracts was performed on rabbits tested in 
cadmium chloride (Cd) treated rabbits. The effects of aqueous and 
ethanolic extracts of Raphanus sativus significantly decreased the total 
bilirubin level and activity of enzymes of ALT and ALP in serum of Cd-
treated rabbits (Zaman and Ahmad, 2004 ). 
 Vitoria et al (2001) investigated the antioxidant responses of radish 
(Raphanus sativus ) to cadmium (Cd) treatment. The results suggest that 
the activity of antioxidant enzymes in radish responds to cadmium (Cd) 
treatment. The main response may be via the activation of the ascorbate-
glutathione cycle for the removal of hydrogen  peroxide, or to ensure the 
availability of glutathione for synthesis of cadmium (Cd) binding 
proteins, these findings are in accord with Takaya et al (2003) also.   
 Tawfik et al (1978) reported the presence of alkaloids, coumarins, 
saponins, flavonoids and anthocyanine in the seed and fruit of Raphanus 
sativus. However, Songsak and Lockwood (2002) reported that Raphanus 
sativus contained sulforaphene, sulforaphane, glucodehydroerucin and 
gluconapin.  
 The naturally derived isothiocyanate, sulphoraphene, isolated from 
seeds of Raphanus sativus was investigated for it’s antigenotoxic effects 
against some bacterial strains mutant (Shishu and Kaur 2003).  
 Treatment with aqueous extract of the bark of Raphanus sativus 
showed a significant decrease in the weight of stones tested hence it’s 
antiurolithiatic and diuretic activity (Vargas et al, 1999). 
 The effect of black radish root of Raphanus sativus.L was studied 
on the structure and redox state of the colon mucosa in rats fed fat-rich 
diet. The epithelial cells disrupted, the number of enterocytes and the 
goblet cells reduced and inflammatory cells were observed in rats fed 
with a fat -rich diet. After treatment with granules from black radish root 
all of the histopathological changes and parameters of the redox state 
caused by the fat-rich diet were improved. The structure of epithelial cells 
was similar to the controls, the number of goblet cells increased and no 
inflammation was observed (Sipos et al, 2002 ) 
 A Raphanus sativus niger water extract was administered by 
intranasal instillations to mice before inoculation with the influenza virus 
strain. The extract ensured some protection against the experimental 
influenza infection. A significant decrease of the haemagglutinin titre of 
the mouse lung homogenate was noted, as well as a decrease of the 
mortality rate and a significant increase of the rate of survival as 
compared to the untreated controls (Prahoveanu and Esanu 1987 ). 
 Nakamura et al (2001) found that the n-hexane extracts from eight 
strains of daikon (Raphanus sativus; Japanese white radish ) had 
antimutagenic activity against UV- induced mutation assay of 
Escherichia coli due to 4-methylthio-3-butenyl isothiocyanate. 
 The plant Lepidium sativum, the common names is cress, pepper 
cress, garden cress, pepper grass and pepper wort, the Arabic name is EL 
Rashad. The plant is glabrous erect annual, the leaves and seed contain 
volatile oils known as cress-oil (Watt and Breyer-Brandujk 1962 ). 
 Lepidium sativum is cultivated in Khartoum and Kordofan 
provinces. The leaves are entirely to pinnatisect, the flowers white and 
the seeds is siliqua obovate to nearly rotundate, emarginated. The 
growing plant is eaten and the seeds yield an oil which are used in 
treating dysentery and diarrhea (Broun and Massey, 1929). 
 Lepidium sativum contained benzyl glucosinolate and 
glucotropaeolin as reported by Songsak and Lockwood (2002).  
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            CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1. Materials and Experimental Designs  
2.1.1. Plants 
 Plants were obtained from Omdurman General Market and 
identified by the Medicinal and Aromatic Plants Research Institute 
(MAPRI). 
   Raphanus sativus is cultivated every where.Lepidium sativum is 
cultivated in Khartoum and Kordofan provinces. The seeds of two plants 
were powdered to prepare the extraction.   
 
2.1.2. Animals 
 Wistar albino rats of both sexes weighing 60- 145 gm were used. 
They were kept in cages and housed in standard environmental conditions 
of temperature, humidity and light within the premises of MAPRI.  The 
rats were left for seven days adaptation and supplied with standard diet 
and water adlibitum. 
 2.1.3. Experimental Designs and Parameters  
 Six experiments were performed to study the hepatoprotective 
activity of the plant. Other two experiments were carrying out to study 
the toxicity of the plants. 
 Two different extracts of R. sativus and L. sativum were tested for 
their hepatoprotective activity against carbon tetrachloride induced liver 
damage in rats. The degree of protection was measured by using 
biochemical parameters like serum transaminases (SCOT and SGPT), 
alkaline phosphatase (AP) and total bilirubin (Ahmed B. et al, 2002).  
 In each hepatoprotective experiment twenty rats were used. After 
seven days adaptation period they were divided randomly into 4 groups, 5 
rats in each. The animals were injected intraperitonial daily through out 
the experimental period which was 10 days. 
 Group (A) served as control and was injected with paraffin oil at a 
dose of (0.2 ml/kg).  In the other three groups (B, C, and D) liver damage 
was produced by injection of carbon tetrachloride (CCl4), which mixed 
with 9th volume of liquid paraffin oil. Rats in groups (C) and (D) received 
plant extract at a dose of 200mg/kg and   400mg/kg respectively. 
 For toxicology study twelve rats were divided to three groups, four 
rats in each. Group (1) was served as control. Group (2) and (3) received 
daily for 21 days plant extract orally at dose 200mg/kg and 400 mg/kg 
respectively. 
 
 
 
Parameters: - 
 Blood sample were collected using halothane as anaesthesia 
(Green, 1979) from the orbital plexus (Wayn Forth, 1980) for hematology 
(PCV, Hb, RBCs, MCV and MCHC ) and serum analysis. Sera were 
analyzed for activities of serum transaminases, alkaline phosphatase and 
total bilirubin. Blood sample were taken before and after dosing with 
plant extract. 
 Samples from the liver, heart, kidney, lung, and pancreas were 
collected immediately after slaughter and fixed in 10% formaline for 
histopathology. 
2.2. Methods 
2.2.1. Plants Extraction 
 The plants seeds were dried and extracted according to Harborne 
(1976) method. 
Aqueous Extract:- 
 One hundred grams of granulated seeds of R. sativus was weighed 
and covered with boiling water for two hours, then filtered. The filtrate 
was frozen dried till use.  
Methanolic Extract:- 
 Sixty gm of granulated seeds from each of the two plants were 
weighed and packed in soxhlet apparatus (Quick Fit, Ex 5183). 100 ml of 
chloroform was used as a solvent to separate lipids and terpenoids.  
 The samples were unpacked and left to dry then  repacked again 
with methanol (Analar) as a solvent to get the polar constituents of the 
plants, the extract were evaporated till dryness using arotavapor (BUCHI  
011). 
Ethanolic Extract:- 
 Sixty gm of granulated seeds of L. sativum was weighed and 
packed in soxhlet apparatus (Quick Fit, Ex 5183). 100 ml of chloroform 
was used as a solvent to separate lipids and terpenoids. The sample was 
unpacked and left to dry, then repacked again with ethanol as a solvent. 
The extract was evaporated by rotavapor (BUCHI  011) till dryness. 
 
2.2.2. Phytochemical Screening 
 Tests for sterols, triterpenses, alkolaids, flavonoids, tannins, 
saponins, cyanogenic glycoside, anthraquinone glycoside and cumarins 
were carried out using the method of Harborne (1976).  
 Ten gm of the powder plant kernel were refluxed with 100 ml of 
80% of ethanol for 4 hours. The cool solution was filtered and enough 
80% ethanol was passed through the volume of the filtrate up to 100 ml. 
This prepared extract (PE) was stored to be used for the phytochemical 
screening which give information about the nature of constituents found 
in each plant sample. 
Tested for Unsaturated Sterols and Triterpenses:- 
 Ten ml of the prepared extract (PE) of the plant was evaporated to 
dryness on a water bath and the cold residue was stirred several times 
with petroleum ether to remove most of the coloring materials. The 
residue was extracted with 20 ml chloroform. The chloroform solution 
was dehydrated over sodium sulphate anhydrous. 5 ml portion of the 
chloroform solution was mixed with 0.5 ml of acetic anhydride followed 
by 2 drops of concentrated sulphuric acid. The gradual appearance of 
green to blue color was taken as an evidence of the presence of sterols 
while pink to purple was indicative of triterpenses.  
Test of Alkaloids:- 
 7.5 ml of the prepared extract (PE) was evaporated to dryness on 
water bath. 5% ml of 2N HCl was added and stirred while heating on 
water bath for 10 minutes then cold, filtered and divided into two test 
tubes. To one tube few drops of Mayer’s reagent was added while the 
other tube few drops of valser’s reagent was added. A slight turbidity of 
heavy precipitate in either of the two test tubes was taken as presumptive 
evidence for the presence of alkaloids. 
 
 
Test for Flavonoids:-  
 17.5 ml of the prepared extract (PE) was evaporated to dryness on 
water bath, and then cooled and the residue was defatted by several 
extractions with petroleum ether. The defatted residue was dissolved in 
30 ml of 80% ethanol and filtered. The filtrate was used for following 
tests: - 
(A) To 30 ml of filtrate in a test tube 1 ml of 1% aluminum chloride 
solution was added. Formation of a yellow color indicated the 
presence of flavonoids. 
(B) To 3 ml of the filtrate in a test tube 1 ml of 1% potassium 
hydroxide solution was added. A dark yellow color indicated 
the presence of flavonoids. 
 
Tests for Tannins: - 
 Seven ml of prepared extract (PE) was evaporated to dryness on a 
water bath. The residue was extracted several times with n- hexane and 
filtered. The insoluble residue was stirred with 10 ml of hot saline 
solution. The mixture was cooled, filtered and the volume of the filtrate 
was adjusted to 10 ml with saline solution. Four drops of the gelatin salt 
reagent was added to 5 ml of the solution, immediate formation of 
precipitate was taken as evidence for presence of tannin. Few drops of 
ferric chloride reagent were added to another portion of the solution. 
Formation of blue, black or green color indicated the presence of tannins.   
 
Test for Saponins: - 
 Ten ml of distilled water was added to 1 gm of the original dried 
powder plant material in a clean test tube, and vigorously shaken for 
about 30 seconds. Formation of honey comb, which persisted for at least 
an hour, was taken as evidence for presence of Saponins.  
 
Test for Cyanogenic glycoside: - 
 Sufficient water was added to 3 gm of the powdered plant so as to 
be moisten, and then add 1 ml of chloroform. Apiece of sodium picrate 
paper was carefully inserted between a split crocks. A change in color of 
the sodium picrate paper from yellow to various shades of red was an 
indication of the presence of cyanogenic glycoside. 
 
Test for Anthraquinone glycoside: - 
 Ten ml of 0.5 N KoH mixed with 1 ml of 3% hydrogen peroxide 
were boiled with 10 gm of the powdered plant sample, and the mixture 
was extracted by shaking with 10 ml of benzene. 
 5 ml of the benzene solution was shaken with 3 ml of 1% 
ammonium hydroxide solution then added to the mixture. Formation of 
pink or red alkaline layer was an indication of the presence of 
anthraquinone glycoside.  
 
Test for Cumarins: - 
 Three gm of the original powdered plant sample was boiled with 
20 ml distilled water in test tube. Filter paper with spot of 0.5 N KoH was 
attached to the test tube to be saturated with the vapor, then the filter 
paper was inspected under UV light. The presence of cumarins was 
indicated if the spot absorbed the UV light. 
 
2.2.3. Haematology 
 Haematological methods were performed as described by Schalm 
(1965). Blood samples were collected into dry clean tube containing 
anticoagulant EDTA. 
Haemoglobin Concentration (Hb)  
 The concentration of Hb was determined by the 
cyanmethaemoglobin technique using spectrophotometer. A volume of 
0.01 ml of blood was added to 2 ml of Drabkin’s solution (0.2 gm 
potassium cyanide, 0.2 gm potassium ferricyanid and 1 gm sodium 
bicarbonate per liter distilled water). After 10 min. the Hb concentration 
was measured in gm/dl of blood. This method is based on the conversion 
of haemoglobin by Drabkin solution to cyanmethaemoglobin.  
Packed Cell Volume (PCV)  
 Fresh blood samples were collected in microhaematocrit capillary 
tubes, and centrifuged in a microhaematocrit centrifuge (Hawksly and 
sons Ltd Englank) for five minutes. Packed cell volume Percent was read 
off on the scaling instrument provided with centrifuge. 
Red Blood Cells Count (RBCs)  
 RBCs were counted with an improved neubauer haemocytometer 
(Hawksley and Sons Ltd, England). Hayem’s solution was used as a 
diluents consisting of 0.5 gm sodium sulphate, 0.5 mercuric chloride and 
1 gm sodium chloride made up to 200 ml with distilled water. 
Mean Corpuscular Volume (MCV)  
 The MCV was calculated from PCV and RBC values as 
following:- 
  MCV     =   PCV × 10/ RBC × 106 
Mean Corpuscular Hemoglobin Concentration (MCHC)  
 The MCHC was calculated from Hb and PCV values as following:-  
  MCHC   =    Hb (gm/dl) × 10 / PCV 
 
2.2.4. Biochemical Analysis 
 The biochemical analysis AP, SGOT, SGPT and serum bilirubin 
were estimated to assess the liver function (Mandal, S. C. et al, 1999). 
Serum was separated by centrifugation at the centrifuge (HETTICH EBA 
35 centrifuge). 
 
Alkaline Phosphatase (AP) 
 This is an optimised standard method according to the 
recommendation of Chemie (1972). 
Principle: - 
 Serum AP, splits p- itrophenyl phosphate, in an alkaline medium, 
in the presence of Mg+2 ions, into p-nitrophenyl which is  yellow in 
colour. The optical density is measured at wavelength 405nm.The 
intensity of the colour produced is proportional to the ALP activity in the 
sample.  
                                                                            
p- nitrophenyl phosphate +H2o               phosphate  +  p- nitrophenyl 
 
Calculation: - 
  ALP I/U =   A 405 nm/min × 2760 
 A    =  The mean sample absorbance reading. 
Glutamic Pyruvic Transaminases (GPT), Alanine Amino Transferase 
(ALT) 
 Glutamic pyruvic transaminase activity in serum measured 
according to of Reitman and Frankel (1957) and Schmidt and Schmidt 
(1963) method. 
Principle: - 
 GPT activity is measured by monitoring the concentration of 
pyruvate hydrazone formed with 2.4- dinitrophenyl hydrazine. 
 
                                                             
 α  -oxoglutarate  +  L- Alanine              L- glutamate  +  pyruvate 
AP 
GoT 
 The absorbance of samples were read against the reagent blank 
after 5 min. at wave length 546 nm in JENWAY 6305 UV/VIS 
spectrophotometer. GPT was measured in U/I. 
 
Glutamate Oxaloacetate Transaminase (GOT), Aspartate Amino 
Trasferase (AST) 
 Glutamate oxaloacetate transaminase activity  in serum measured 
according to of Reitman and Frankel (1957) and Schmidt and Schmidt 
(1963) method . 
 
Principle:  - 
 GOT activity  is measured by monitoring the concentration of 
oxaloacetate hydrozone formed with 2- 4 dinitrophenyl- hydrazine.  
                                                                  
α -oxoglutarate + L- asparatate  L- glutarate + oxaloacetate 
 The absorbance of samples were read against the reagent blank 
after 5 min. at wave length 548 nm in JENWAY 8305 UV/VIS 
spectrophotometer. 
 
 
Got
Total Bilirubin 
 The total bilirubin in serum measured as stated by Jendrassik and 
Grof (1938). 
Principle: - 
 Bilirubin is coupled with diazotised sulfanilic acid in the presence 
of caffeine to give an azodye. The optical density was measured by 
JENWAY 6305 UV/VIS spectrophotometer at wavelength 540 nm. 
 Total bilirubin calculated as follow: - 
 Total bilirubin (mg/dl)  =  Total absorbance  ×  17.5   
2.2.5. Histopathology 
 The specimens of tissues were collected immediately after death of 
animals, fixed in 10% buffered formaline, embedded in paraffin wax, 
section at 5 nm and stained with haematoxylin and eosin (Drury and 
Wallington, 1980). 
 
2.2.6. Statistical Analysis 
 Data were analysed for significance using the students’ t-test 
according to procedure described by Menden Hall (1971). 
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CHAPTER THREE 
 RESULTS  
Phytochemical Screening:- 
The nature of  the  constituents found in the plants Raphanus 
sativus and Lepidium sativum were shown in table (1). 
Both plants were positive for triterpenses, alkaloids, flavonoids and 
cumarins but negative for cyanogenicglycoside and 
anthraquinoneglycoside. Raphanus sativus was positive for saponins 
while Lepidium sativum was negative. 
1. Effects of Methanolic Extract of Raphanus sativus Against CCl4  
1.1. Clinical Finding:- 
There were no clinical signs seen in group (A), (C),(D).In group(B) 
depression, loss of appetite, decrease of weight and increase of the 
sleeping time were noticed. 
1.2. Postmortem Finding:-  
In group (A) there were no pathological changes seen in the  
organs, but in group(B) the postmortem changes observed were necrosis, 
fatty changes and haemorrhage in the liver and congested lung. In 
group(C) (200mg/ kg) there was moderate fatty change in the liver. In 
group (D) (400 mg/kg) there were mild fatty changes in the liver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Raphanus sativus Lepidium sativum 
Triterpenses +ve +ve 
Alkaloids +ve +ve 
Flavonoids +ve +ve 
Tannins +ve +ve 
Saponins +ve -ve 
Cyanogenicglycoside -ve -ve 
Anthraquinoneglycoside -ve -ve 
Cumarins +ve +ve 
Table (1):-The Phytochemical Screening of Raphanus sativus  
                  and Lepidium sativum 
1.3. Haematological Changes:- 
The mean values of RBCs, Hb, PCV, MCV and MCHC were  
Summarized in table (2).  
In group (B) there were significant transient decrease (p≤0.05)  
In the Hb concentration, RBCs at day 5 and significant decrease (p≤0.05) 
in the values of PCV and MCV at day 10. 
 In group (C) ,200mg/kg, and group(D),400mg/kg,  there were  
Significant increase (p≤0.05) in Hb concentration at day 5.  
 1.4. Serum Constituents Change:- 
  The means level of AST, ALT, AP and bilirubin were shown  
  in table (3) and Figures 9-12.  
In group (B) there were significant increase (p≤0.05) in the  
  levels of AST at day 5 and ALT, AP and bilirubin at day 10. 
 In group(C) there were significant increase (p≤0.05) in the  
   levels of ALT, AP and bilirubin at day 5.  
 In group (D) there were significant increase (p≤0.05) in the  
   levels of ALT and AP at day 5 but the bilirubin level was not    
Changed. However at day 10 there was slight increase in the level of    
ALT and even a decrease in AP level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCV 
Groups Day 0 Day 5 Day 10 
A  37.2±1.2 34.0±1.4 36.0±1.8 
B 37.2±0.7 37.2±2.6   32.4±1.6* 
C 34.4±2.7 35.6±1.2 34.8±1.2 
D 35.4±1.2 34.6±1.7 34.8±1.5 
Hb 
Groups Day 0 Day 5 Day 10 
A  11.40±2.9 13.00±1.2 12.10±1.2 
B 16.50±1.3   10.83±1.2* 12.80±1.4 
C 13.14±0.5  19.64±1.7* 15.14±1.8 
D 12.36±0.6  23.42±2.4* 19.90±1.3 
RBCs 
Groups Day 0 Day 5 Day 10 
A  558.2±88.70 259.6±55.00 203.6±28.40 
B 436.2±63.70  299.0±40.70* 334.2±47.40 
C 334.2±44.90 335.6±32.40 238.8±17.60 
D 274.2±22.07 292.6±23.05 267.4±21.05 
MCV 
Groups Day 0 Day 5 Day 10 
A  76.00±15.70 154.4±33.1 195.8±34.6 
B 94.60±16.08 142.2±35.2  117.0±29.5* 
C 111.8±21.10 110.8±12.2 148.0±8.90 
D 132.00±9.80 121.6±12.4 133.4±11.4 
MCHC 
Groups Day 0 Day 5 Day 10 
A  30.60±7.6 38.4±3.5 33.8±4.1 
B 44.62±3.5 29.5±3.6 40.2±5.6 
C 42.00±1.3 55.2±4.3 43.2±4.3 
D 34.8±0.6 69.4±6.6 57.2±2.5 
Table (2):- Haematology values in rats treated with methanolic  
                   extract of Raphanus sativus ,paraffin and CCl4                
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         AST U/I (Mean ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  26.0 ± 2.2 20.2 ± 0.6 29.0 ± 1.8 
B 16.4 ± 0.5  25.4 ± 2.5*  78.8 ± 4.3* 
C 15.4 ± 5.1 21.8 ± 0.0 17.8 ± 3.2 
D 15.7 ± 2.7 19.2 ± 7.9 16.8 ± 6.8 
                        ALT U/I (Mean ±S.E) 
Groups Day 0 Day 5 Day 10 
A  30.2± 0.90 21.40 ±  0.7 27.20 ± 0.7 
B 29.0 ± 0.70 74.00 ± 0.7  115.0 ± 1.3* 
C 68.5 ± 4.70  86.00 ± 0.0* 79.80 ± 2.8 
D 74.5 ± 1.02  109.6 ± 4.6* 77.00 ± 0.3 
                       Bilirubin mg/dI (Mean ± S.E) 
Groups Day 0 Day 5 Day 10 
A  0.8 ± 0.30 0.8 ± 0.2 0.80 ± 0.10 
B 0.7 ± 0.10 0.7 ± 0.1 1.06 ± 0.20* 
C 0.4 ± 0.03 1.0 ± 0.0* 0.50 ± 0.03 
D 0.5 ± 0.03 0.5 ± 0.03 0.54 ± 0.07 
                            AP U/I (Mean ± S.E )
Groups Day 0 Day 5 Day 10 
A  411.8 ± 37.6 407.9± 18.40 338.9 ± 25.7 
B 324.6 ± 22.6 327.1 ± 16.50  358.2 ± 3.70* 
C 290.4 ± 62.3  512.0 ± 0.000* 330.8± 61.5 
D 347.7 ± 63.0 672.6 ±140.7* 234.6 ± 49.8 
Table (3):- Serum constituents values in rats treat  with methanolic    
                   extract of Raphanus sativus   ,paraffin and CCl4 
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Fig (9) Changes in serum AST in rats given methanolic extract of Raphanus 
sativus
Fig(10) Changes in serum ALT in rats given methanolic extract of Raphanus 
sativus 
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Fig (11) Changes in serum AP in rats given methanolic extract of Raphanus 
sativus
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Fig (12) Changes in serum BiL in rats given methanolic extract of 
Raphanus sativus 
1.5. Histopathological Changes:-  
In group (B) which injected by CCl4 massive vaculation congestion 
of the central vein, degeneration and inflammatory infiltration of 
lymphocytes around the central veins were evident. Fig.(13b)  
In group (C) the treatment group with (200mg/kg) the liver showed 
moderate vaculation and congestion. Fig. (13c) 
 In group(D) the treatment group with (400mg/kg) the liver showed 
mild vaculation. Fig. (13d) 
 In group(A) the control group no pathological changes were seen. 
Fig. (13a)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (13): Section of livers of rats given methanolic extract of Raphanus sativus and  
               CCl4.  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
(a) control group  
                                                                               (b) Ccl4 group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(c) 200mg/kg 
                                                                                  (d) 400mg/kg 
 
 
 
 
 
  
 
 
 
 
 
 
 
2. Effects of Water Extract of Raphanus sativus Against CCl4  
2.1. Clinical Finding:- 
  Rats in group(B) received ccl4 exhibited dullness, reduction of 
weight and depression. There were no clinical signs observed in rats of 
the other groups. 
2.2. Postmortem Finding:- 
The control group ,group(A), there were no postmortem  
changes. The group which  received CCl4 group(B) the liver is pale and 
haemorrhagic, heart and lung were  congested. In group recieved  
(200mg/kg) group (C) there were slight paleness and congestion of the 
liver and congested lung. In group received  (400mg/kg) group(D) there 
was slightly congestion in the liver. 
2.3. Haematological Changes:- 
 The mean values of RBCs, Hb, PCV, MCV and MCHC were  
summarized in table (4).  
There were significant decrease (p≤0.05) in the values of the  
MCV at day 5 and 10 and MCHC at day 10 in group (B). 
In group (C)  there  were significant decrease  (p≤0.05) in the  
values of the MCV at day 5 and MCHC at day 10.  
In group (D) there were significant decrease (p≤0.05) in the values 
of the PCV and MCV at day 5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCV 
Groups Day 0 Day 5 Day 10 
A  37.4±1.2 32.4±1.6 29.8±2.0 
B 34.6±2.6 34.4±1.6 35.4±2.4 
C 36.0±1.0 35.2±1.5 37.6±1.9 
D 40.0±1.5  32.0±0.6* 35±3.05 
Hb 
Groups Day 0 Day 5 Day 10 
A  13.28±1.0 11.58±1.2 11.12±0.95 
B 13.66±1.2 14.26±1.1 11.26±0.40 
C 14.92±1.5 13.86±0.7 12.50±0.96 
D 12.70±0.8 14.10±1.8 13.24±1.00 
RBCs 
Groups Day 0 Day 5 Day 10 
A  419.8±40.03 328.6±29.02 264.2±25.9 
B 157.6±47.90 269.6±32.40 355.2±30.7 
C 311.6±26.70 372.8±51.80 285.2±36.1 
D 335.2±42.30 312.0±20.20 310.6±28.3 
MCV 
Groups Day 0 Day 5 Day 10 
A  93.60±12.5 102.4±12.03 115.2±8.60 
B 254.2±68.6  137.0±20.95*  103.0±12.6* 
C 118.8±11.3 106.4±23.40* 137.4±11.4 
D 134.0±24.1 104.2±8.40* 113.2±3.50 
MCHC 
Groups Day 0 Day 5 Day 10 
A  35.4±2.30 35.8±3.50 37.2±1.4 
B 40.8±5.04 41.8±3.80 33.2±2.4* 
C 41.6±4.30 39.6±3.03 33.4±2.7* 
D 32.0±3.20 44.0±5.60 38.0±1.6 
Table (4):- Haematology  values in rats treated with water  
                    extract of Raphanus sativus , paraffin and CCl4 
   2.4.Serum Constituents Changes:- 
 The different levels of AST, ALT, AP and bilirubin were shown in 
table (5) and Figures 14-17. 
In group(B) there were significant increase (p≤0.05) in the levels 
of the AST at day 5 and day 10 also ALT and bilirubin at day 10. 
 In group(C) there were significant increase in the levels of AST 
and ALT at day 5 and  significant  increase  (p≤0.05)  in  the  levels in  
bilirubin at day 5 and 10. In group (D) significant increase (p≤0.05) in 
the levels of AST, ALT and AP at day 5.  
2.5. Histopathological Changes:- 
In the control group there were no changes seen. Fig. (18a).  
Livers from the group that received CCl4 showed  massive vaculation 
and congestion. Fig. (18b). 
 In the group which treated with 200mg/kg the liver showed  necrosis, 
fatty change and congestion. Fig. (18c). 
 While in the group which treated with 400mg/kg  showed mild 
vaculation. Fig.(18d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
                         AST U/I (Mean ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  26.0 ± 2.2 20.2 ± 0.60 29.0 ± 1.8 
B 16.4 ± 0.5  25.4 ± 2.50*  78.8 ± 4.3* 
C 25.4 ± 2.5  46.6 ± 4.50* 26.4 ± 1.8 
D 28.2 ± 2.6  37.6 ± 2.04* 22.8  ± 1.9 
          AP U/I mg/dI (Mean ± S.E) 
Groups Day 0 Day 5 Day 10 
A  411.8 ± 37.6 407.9 ± 18.4 338.9 ± 25.7 
B 324.6 ± 22.6 327.1 ± 16.6 358.2 ± 3.70 
C 311.9  ± 21.5 401.8 ±  18.7 417.3 ± 35.6 
D 305.8 ± 28.8 443.8 ± 16.9* 405.7 ± 15.1 
              ALT U/I (Mean ±S.E) 
Groups Day 0 Day 5 Day 10 
A  17.6 ± 0.9 19.4 ± 0.7 17.0 ± 0.7 
B 16.0 ± 0.7 16.2 ± 0.7  22.0 ± 1.3* 
C 16.4 ± 0.6  19.2 ± 0.9* 16.2 ± 0.4 
D 16.4 ± 0.6  23.4 ± 0.9* 21.8 ± 0.8 
           Bilirubin mg/dl (Mean  ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  0.8± 0.30  0.80 ± 0.20 0.80 ± 0.10  
Table (5):- Serum constituents values in rats treated  with water   
                 extract of Raphanus sativus , paraffin and CCl4 
 
 
 
 
B 0.7 ± 0.06 0.70 ± 0.08 1.06 ± 0.20*  
C 0.8 ± 0.04 1.04 ± 0.10* 1.06 ± 0.10* 
D 0.7 ± 0.05 0.90 ± 0.07 0.80 ± 0.05 
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Fig (15) Changes in serum ALT in rats given water extract of Raphanus 
sativus
Fig (14) Changes in serum AST in rats given water extract of Raphanus sativus 
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Fig (16) Changes in serum AP in rats given water extract of Raphanus  
                                                  sativus  
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Fig (17) Changes in serum BiL in rats given water extract of Raphanus 
sativus  
Fig (18): Section of livers of rats given water extract of Raphanus sativus and  
               CCl4.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) control group  
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. Effect of Methanolic Extract of Lepidium sativum Against CCl4  
3.1. Clinical Finding:- 
 No clinical signs were observed in all groups except for dullness in 
rats received CCl4.  
3.2. Postmortem Finding:- 
 No postmortem changes in group(A) were seen. In group(B) the 
liver was pale and fatty. In group (C) the liver was congested and 
moderately fatty. In group(D) the liver was fatty and congested. 
3.3. Haematological Changes:- 
 Table(6) shows the mean vales of RBCs, Hb, PCV, MCV and 
MCHC. Significant decrease (p≤0.05)  in the values of the Hb and 
MCHC at day 10 and the RBCs at day 5 and 10 were observed in 
group (B).  
 In group (C) there were significant increase (p≤0.05) in value of 
PCV at day 5 and significant decrease (p≤0.05) in the value of Hb at 
day 10. 
 In group (D) there were significant increase (p≤0.05) in the value 
of PCV and Hb at day 10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCV 
Groups Day 0 Day 5 Day 10 
A  33.4±1.20 32.2±0.9 32.0±0.7 
B 34.2±1.02 29.2±0.9 30.6±2.1 
C 34.6±0.90  38.4±0.5* 34.0±1.3 
D 36.0±1.20  39.8±2.0* 35.4±1.3 
Hb 
Groups Day 0 Day 5 Day 10 
A  11.18±0.40 10.78±0.3 10.76±0.3 
B 12.26±0.40 10.06±0.4  7.500±0.8* 
C 14.16±0.30 15.32±0.6  12.48±0.4* 
D 12.00±0.92  14.94±0.7* 12.34±0.5 
RBCs 
Groups Day 0 Day 5 Day 10 
A  512.8±37.9 448.0±19.0 461.4±33.1 
B 462.6±15.0 316.4 ±27.3*  261.2±15.5* 
C 366.6±31.0 489.0 ± 47.9 407.4±34.9 
D 414.8±25.2 523.8±74.3 350.2±23.3 
MCV 
Groups Day 0 Day 5 Day 10 
A  66.04±3.2 72.22±2.6 70.26±3.30 
B 74.02±1.7 94.68±7.2 117.64±6.70 
C 96.60±7.2 81.60±8.2 85.60±6.80 
D 88.00±5.3 80.60±8.4 103.0±7.04 
MCHC 
Groups Day 0 Day 5 Day 10 
A  33.46±0.1 33.44±0.1 33.68±0.4 
B 35.98±1.4 34.00±0.8 24.26±1.6* 
C 41.00±1.1 39.60±1.8 36.80±1.9 
D 33.20±2.9 38.00±2.7 34.80±1.4 
Table (6):- Haematology  values in rats treated with methanolic 
                    extract of Lepidium sativum , paraffin and CCl4 
3.4. Serum Constituents Changes:- 
 Table (7) and Figures 19- 22 show the mean levels of AST, ALT, 
AP and bilirubin.  
In group(B) there were significant increase (p ≤ 0.05) in the levels 
of AST, ALT and AP at day 5 and 10.Also the bilirubin at day 10. 
 In group (C) there were significantly increase (p ≤ 0.05) in the 
levels of the bilirubin at day 5,10 and AP at day 10. 
In group (D) there were significant increase (p ≤ 0.05) in the level 
of AP and bilirubin at day 10.  
3.5. Histopathological Changes:- 
There were no pathological changes observed in group (A). Fig. 
(23a). 
In group (B) (CCl4 group ) massive vaculation and congestion in 
the central vein was noticed. Fig. (23b). 
In group (C) (200 mg/kg) the liver showed moderate vaculation 
and congestion. Fig.(23c). 
In group (D) (400 mg/kg) the liver showed massive vaculation and 
congestion. Fig. (23d). 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         AST U/I (Mean ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  28.8 ± 3.30 31.60 ± 4.90 39.20 ± 4.90 
B 34.3 ± 6.90 215.6 ± 13.1* 286.4 ± 45.3* 
C 22.3 ± 12.4 21.10 ± 5.70 19.80 ± 4.30 
D 20.2 ± 3.50 19.50 ± 1.80 19.70 ± 7.40 
              ALT U/I (Mean ±S.E) 
Groups Day 0 Day 5 Day 10 
A  30.2 ± 4.7 21.4 ± 4.7 27.20 ± 6.80 
B 29.0 ± 2.8  74.0 ± 5.4* 115.6± 16.3* 
C 71.0 ± 4.8 76.2 ± 4.0 69.40 ± 8.40 
D 69.0 ± 7.6   74.2 ± 0.7 75.40 ± 9.40 
          AP U/I mg/dI (Mean ± S.E) 
Groups Day 0 Day 5 Day 10 
A  384.8 ± 35.7 451.8 ± 78.8 364.6 ± 25.1 
B 293.3 ± 30.3  895.0 ± 45.7* 987.8± 66.3* 
C 502.4 ± 4.4 584.0 ± 37.2 693.4± 82.2* 
D 439.6 ± 58.2 502.4 ± 31.6 559.0± 23.8* 
           Bilirubin mg/dl (Mean  ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  0.15 ± 0.02  0.2± 0.03  0.2 ± 0.04 
B 0.23 ± 0.03 0.5 ± 0.09 1.0 ± 0.07* 
C 1.00 ± 0.07 1.2 ± 0.20* 1.4 ± 0.50* 
D 1.00 ± 0.10 1.0 ± 0.10 1.3 ± 0.20* 
Table (7):- Serum constituents values in rats treated  with  
                 methanolic extract of Lepidium sativum , paraffin and  
                 CCl4 
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Fig (19) Changes in serum AST in rats given methanolic extract of Lepidium 
sativum 
Fig(20) Changes in serum ALT in rats given methanolic extract of Lepidium 
sativum 
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Fig (21) Changes in serum AP in rats given methanolic extract of 
Lepidium sativum 
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Fig (22) Changes in serum BiL in rats given methanolic extract of 
Lepidium sativum 
 
Fig (23): Section of livers of rats given methanolic extract of Lepidium sativum and  
               CCl4.  
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4. Effect of Ethanolic Extract of Lepidium sativum against CCl4  
4.1. Clinical Finding:-  
 The clinical signs observed only in rats received CCl4 included 
dullness, decrease in body weight and lost of appetite.  
4.2. Postmortem Finding:- 
 In group (C) the liver showed fatty change and haemorrhage and 
the lung was congested. In group (D) fatty change was observed in the 
liver. The liver in group (B) showed area of  haemorrhages and 
paleness. In group (A) no postmortem change was observed.  
4.3. Haematological Changes:- 
 Table (8) shows the mean values of RBCs, Hb, PCV, MCV and 
MCHC.  
In group(B) there were significant decrease (p ≤ 0.05) in the values 
of the Hb, RBCs and MCHC at day 10. 
 In group (C) there were significant increase (p ≤ 0.05) in the value 
of the PCV at day 5 and significant decrease  (p ≤ 0.05) in value of 
MCV at day 5 and MCHC at day 10.  
In group (D) there were significant increase (p ≤ 0.05) in the values 
of PCV at day 10 and significant decrease (p ≤ 0.05) in the values of 
the MCV at day 10.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCV 
Groups Day 0 Day 5 Day 10 
A  33.4±1.2 32.2±0.9 32.0±0.7 
B 34.2±1.02 29.2±0.9 30.6±2.1 
C 36.6±1.2  37.2±2.4* 35.6±3.5 
D 35.4±0.8 37.0±1.2  41.0±1.3* 
Hb 
Groups Day 0 Day 5 Day 10 
A  11.18±0.4 10.78±0.3 10.76±0.3 
B 12.26±0.4 10.06±0.4  7.500±0.8* 
C 11.68±0.5 13.94±0.9 11.30±1.8 
D 11.18±0.5 13.84±0.3 12.94±0.3 
RBCs 
Groups Day 0 Day 5 Day 10 
A  512.8±37.9 448.0±19.0 461.4±33.1 
B 462.6±15.0 316.4±27.3  261.2±15.5* 
C 378.2±58.6 386.0±35.2 342.0±60.0 
D 322.8±19.2 340.8±4.80 413.4±41.2 
MCV 
Groups Day 0 Day 5 Day 10 
A  66.04±3.20 72.22±2.67 70.260±3.30 
B 74.02±1.70 94.68±7.20 117.64±6.70 
C 104.0±12.4  98.40±9.30* 110.00±10.9 
D 111.6±8.40 108.4±3.60 102.40±8.40* 
MCHC 
Groups Day 0 Day 5 Day 10 
A  33.46±0.1 33.44±0.1 33.68±0.4 
B 35.98±1.4 34.00±0.8 24.26±1.6* 
C 32.00±2.1 38.00±3.2  31.40±3.1* 
D 31.60±1.1 37.60±1.1  31.80±0.6* 
Table (8):- Haematology  values in rats treated with ethanolic  
                   extract of Lepidium sativum , paraffin and CCL4 
4.4. Serum Constituents Changes:- 
 Table (9) and Figures 24- 27 show the means levels of AST, ALT. 
ALP and bilirubin . 
In group (B) there were significant increase (p ≤ 0.05) in the levels 
of AST, ALT and AP at day 5 and day 10 also bilirubin at day 10. 
In group (C) and (D) there were no significant  change in the levels 
of AST, ALT, AP and bilirubin.  
4.5. Histopathological Changes:- 
In group(A) there were no histopathological changes. Fig. (28a).  
In group(B) massive vaculation, fatty change and congestion were 
observed. Fig. (28b).  
In group(C) (200mg/kg ) there were moderate vaculation and 
congestion in the liver. Fig. (28c). 
In group (D) (400mg/kg ) the liver showed massive vaculation. Fig. 
(28d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         AST U/I (Mean ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  28.8 ± 03.3 31.60 ± 04.9 39.20 ± 04.9 
B 34.3 ± 06.9 215.6 ± 13.1* 286.4 ± 45.3* 
C 13.1 ±  09.1 16.60 ± 14.4 17.20 ± 10.0 
D 15.3 ± 17.1 14.8 0 ± 16.6 15.00 ± 7.20 
              ALT U/I (Mean ±S.E) 
Groups Day 0 Day 5 Day 10 
A  30.2 ± 4.7 21.4 ± 4.7 27.20 ± 6.80 
B 29.0 ± 2.8  74.0 ± 5.4* 115.6± 16.3* 
C 38.8 ± 1.9 58.0 ± 10.3 55.80 ± 6.00 
D 49.0 ± 6.0 58.6 ± 12.4 48.80 ± 5.30 
          AP U/I mg/dI (Mean ± S.E) 
Groups Day 0 Day 5 Day 10 
A  384.8 ± 35.7 451.8 ± 78.8 364.6 ± 25.1 
B 293.3 ± 30.3  895.0± 45.7* 987.8± 66.3* 
C 469.2 ± 61.5 479.4 ± 80.2 341.0 ± 30.8 
D 330.4 ± 65.7 455.8 ± 65.6 455.4 ± 44.1 
           Bilirubin mg/dl (Mean  ± S.E ) 
Groups Day 0 Day 5 Day 10 
A  0.15 ±  0.02  0.2 ± 0.03 0.2 ± 0.04 
B 0.20 ± 0.03 0.5±  0.09  1.0 ± 0.07* 
C 0.80 ± 0.04 0.9 ± 0.07 0.9±  0.04  
D 0.70±  0.07  0.6 ± 0.06   0.7 ± 0.05 
Table (9):- Serum constituents values in rats treated with  
               ethanolic extract of Lepidium sativum , paraffin and  
               CCl4 
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Fig (24) Changes in serum AST in rats given ethanolic extract of 
Lepidium sativum 
Fig (25) Changes in serum ALT in rats given ethanolic extract of  
Lepidium sativum 
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Fig (26) Changes in serum AP in rats given ethanolic extract of Lepidium 
sativum
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Fig (27)Changes in serum BiL in rats given ethanolic extract of Lepidium 
sativum 
Fig (28): Section of livers of rats given ethanolic extract of Lepidium sativum and  
               CCl4.  
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. Toxicity of Methanolic Extract of Raphanus sativus in rats 
5.1. Clinical Finding:- 
 there were no clinical signs observed in the experimental rats. 
However, there were an increase in the body weight in group (B) and 
(C). 
5.2. Postmortem Finding:- 
The liver in group(A), the control, was normal. 
In group(B),200mg/kg, there was mild haemorrhage in the liver. 
Also group(C),400mg/kg, there was haemorrhage in the liver. 
5.3. Haematological Changes:- 
 The means values of RBCs, Hb, PCV, MCV and MCHC were 
shown in table (10). 
There were significant increase (p ≤ 0.05) in the value of MCV at 
day 21 in group (B). There were no significant change in the values of 
the RBCs, Hb, PCV, MCV and  MCHC in the other groups.        
5.4. Serum Constituents Changes:- 
 The means level of AST, ALT. AP and bilirubin were shown  
in table (11) and Figures 29-32. 
    In group (B) and(C) there were no significant change in the levels 
of AST, ALT, AP and bilirubin.  
5.5. Histopathological Changes:- 
            There were no histopathological changes in group(A),the control 
group. Fig. (33a). 
In group (B),200mg/kg, the liver showed slight congestion and  
dilation of sinusoids. Fig. (33b). 
In group (C), 400mg/kg, the liver showed congestion, 
disorganization of hepatocyte and dilatation of the hepatocyte. Fig. 
(33c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     PCV 
Groups Day 0 Day 21 
A 35.25±0.3 37.00±1.7 
B 35.25±0.8 38.75±1.7 
C 34.75±0.9 39.75±0.6 
            Hb 
    Groups Day 0 Day 21 
A  11.450±0.6 12.45±0.6 
B 11.725±0.7 12.90±0.6 
C 10.900±0.5 13.25±0.2 
            RBCs 
      Groups Day 0 Day 21 
A  305.00±24.6 271.50±47.6 
B 157.75±13.6 410.75±33.5 
C 445.00±17.6 396.25±34.2 
              MCV 
     Groups Day 0 Day 21 
A  118.25±10.4 129.50±16.90 
B 79.000±8.40  246.25±159.9* 
C 78.500±3.90 102.250±8.30 
              MCHC 
      Groups Day 0 Day 21 
A  32.50±1.3 33.50±0.50 
B 33.25±1.8 33.25±0.03 
C 31.50±1.4 33.30±0.06 
Table (10 ):-  Haematology  values in rats treated with  
                      methanolic extract of Raphanus sativus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       AST U/I (Mean ± S.E ) 
Groups Day 0 Day 21  
A  124.5 ± 12 155.3 ± 6.00  
B 107.2 ± 12 123.3 ± 10.8  
C 100.7 ± 2.0 128.8 ± 3.60  
 ALT U/I (Mean ±S.E)       
Groups Day 0 Day 21 
A  46.5 ± 6.6 55.5 ± 8.4 
B 37.5 ± 6.1 40.5 ± 3.0 
C 47.6 ± 4.7 48.8 ± 4.7 
 AP U/I  (Mean  ± S.E ) 
Groups Day 0 Day 21 
A  321.0 ± 51.7 293.3 ± 31 
B 341.8 ± 30.8 422.0 ± 35 
C 277.0 ± 8.60 437.8 ± 81 
 Bilirubin mg/dl (Mean  ± S.E ) 
Groups Day 0 Day 21 
A  0.8 ± 0.06  0.7 ± 0.05 
B 0.8 ± 0.04 0.8 ± 0.03 
C 0.7± 0.02  0.8 ± 0.06 
Table (11):- Serum constituents values in rats  
                  treated with methanolic extract of  
                 Raphanus sativus
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Fig (29)Changes in serum AST in rats given methanolic extract of 
Raphanus sativus 
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Fig (30)Changes in serum ALT in rats given methanolic extract of 
Raphanus sativus 
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Fig (31)Changes in serum AP in rats given methanolic extract of 
Raphanus sativus 
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Fig (32)Changes in serum Bill in rats given methanolic extract of 
Raphanus sativus 
Fig (33): Section of livers of rats given methanolic extract of Raphanus sativus. 
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6. Toxicity of Methanolic Extract of Lepidium sativum 
6.1.  Clinical Finding:- 
There were an increase in the body weight and appetite  in 
group(B) and (C). 
6.2. Postmortem Finding:- 
 There were no postmortem changes noticed in group(A). 
In group(B) and (C) there were congestion and fatty change in the 
liver. 
6.3. Haematological Changes:- 
 The mean values of RBCs, Hb, PCV, MCV and MCHC were 
summarized in table (12). 
There were significant increase (p ≤ 0.05) in the value of  MCV at 
day 21 in group (B). 
In group (C) there were significant increase (p ≤ 0.05) in the values 
of PCV, Hb, and MCV at day 21.  
6.4.  Serum Constituents Changes:- 
 The means level of AST, ALT, AP and bilirubin were summarized 
in table (13) and Figures34-37. 
In group (B) and group (C) no Significant alteration in the values 
of AST, ALT, AP and bilirubin were observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     PCV 
Groups Day 0 Day 21 
A 35.25±0.30 37±1.70 
B 33.50±1.04 38±2.04 
C 32.50±0.07  39±1.10* 
            Hb 
    Groups Day 0 Day 21 
A  11.450±0.6 12.450±0.6 
B 11.125±0.2 12.675±0.7 
C 10.925±0.3  13.000±0.4* 
            RBCs 
      Groups Day 0 Day 21 
A  305.00±24.6 271.50±47.6 
B 486.25±43.1 233.75±17.6 
C 397.00±38.2 215.75±16.0 
              MCV 
     Groups Day 0 Day 21 
A  118.25±10.4 129.5±16.9 
B 70.250±4.60  164.0±10.1* 
C 84.750±9.70  183.0±12.4* 
              MCHC 
      Groups Day 0 Day 21 
A  32.50±1.3 33.500±0.50 
B 33.25±1.3 33.325±0.05 
C 33.75±1.1 33.300±0.04 
Table (12):-  Haematology  values in rats treated with  
                       methanolic extract of Lepidum sativum 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       AST U/I (Mean ± S.E ) 
Groups Day 0 Day 21  
A  124.5 ± 12.0 155.3± 6.0  
B 132.0 ± 20.2 140.8 ± 9.4  
C 120.4 ± 3.90 125.3 ± 8.8  
 ALT U/I (Mean ±S.E)       
Groups Day 0 Day 21 
A  46.5 ± 6.6 55.5 ± 8.4 
B 39.6 ± 3.5 47.3 ± 5.3 
C 42.0 ± 0.4 50.8 ± 5.2 
 AP U/I  (Mean  ± S.E ) 
Groups Day 0 Day 21 
A  321 ± 51.7 293.3 ± 31.0 
B 300 ± 0.40 391.8 ± 70.3 
C 349 ± 45.3 439.0 ± 63.1 
 Bilirubin mg/dl (Mean  ± S.E ) 
Groups Day 0 Day 21 
A  0.8 ±  0.06  0.7 ± 0.05 
B 0.9 ± 0.04 0.8 ± 0.09   
C 0.8 ± 0.04 0.8 ± 0.09 
Table (13):- Serum constituents values in rats treated with  
                      methanolic extract of Lepidum sativum 
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Fig (34)Changes in serum AST in rats given methanolic extract of   
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Fig (35)Changes in serum ALT in rats given methanolic extract of 
Lepidium sativum 
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Fig (36)Changes in serum AP in rats given methanolic extract of 
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6.5. Histopathological Changes:- 
The liver was normal in group(A), the control group. Fig (38a)  
In group(B),200mg/kg, congestion was observed in the liver. Fig 
(38b).  
In group(C),400mg/kg, congestion and vaculation were observed in 
the liver. Fig (38c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (38): Section of livers of rats given methanolic extract of Lepidium sativum . 
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(b) 200mg/kg                                                         (c) 400mg/kg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four 
Discussion 
 
 In this study the methanolic and water extracts of  Raphanus 
sativus and methanolic and ethanolic extracts of Lepidium sativum were 
tested in rats to verify or refute their claimed liver protective effect 
against CCl4 hepatotoxicity. The clinical findings showed that the toxic 
signs such as nervousness and weight loss associated with administration 
of  CCl4 were disappeared on prior treatment with either the methanolic 
or the water extracts of  Raphanus sativus. These toxic symptom might be 
attributed to the liver damage caused by CCl4 that to some extent were 
masked by concurrent administration of the studied extracts of Raphanus 
sativus.  
 CCl4 has an adverse effects on the hemopiesis resulting in an 
anaemia. This was counteracted by administration of the two studied 
plants to rats since the  reduction in the haematological parameters was 
un apparent. These results indicated that Raphanus sativus and Lepidium 
sativum are free of an active constituent that might has a haematolytic or 
inhibitory effect on synthesis of any of the studied blood parameters 
(Onyenyili et al,1998).  
 The experimental liver damage was induced by administration of 
carbon tetrachloride is one of the most commonly used hepatoxin. It is 
well documented that carbon tetrachloride is biotransformed under the 
action of cytochrome P450 in the microsomal compartment of liver to 
trichloromethyl radical which readily reacts with molecular oxygen to 
form trichloromethyl peroxy radical (Raucy et al, 1993; Lee et al, 
2003).Both radicals can bind covalently to the macromolecules and 
induce peroxidative degradation of the membrane lipids of endoplasmic 
reticulum rich in poly unsaturated fatty acids (Recknagel 1967; Wu,J. and 
Worton, P.A. 1996).This leads to the formation of lipid peroxides 
followed by pathological changes such as depression of protein synthesis 
(Faroon et al, 1994). 
 It has been hypothesized that one of the principal causes of CCl4- 
induced liver injury lipid peroxidant activity or the inhibition of the  
generation of free radicals is important in the protection against CCl4- 
induced hepatopathy (Castro et al, !974). Schiaffonati, (1997) suggest 
that CCl4 induced liver cell damage due to oxidative stress. Kupffer cells 
have been suggested to play a role in CCl4 hepatotoxicity (Edwards et 
al,1993). 
 In the present study there were an increased serum enzymes and 
bilirubin in rats treated with CCl4 accordance with the results obtained by 
Zafar and Ali (1998); Dobbs et al (2003); Xu,Q. et al (2002). 
 The rise in serum total bilirubin is a common indicator of jaundice, 
that is why miller et al, (1986) have used it as indices of hepatotoxicity. 
This may be that both plants posses free radical that have a benefical 
action againstliver damage induced by CCl4. However the phytochemical 
analysis of both plants showed similar constituents namely triterpenses, 
alkaloids, flavonoids and cumarins and different in saponins which was 
found in Raphanus sativus  this may speculate that these constituente  
might be responsible for the observed protection effects against liver 
damage. 
 However, the mediated suppression of the increased     AST,ALT, 
AP  and bilirubin  activities by Raphanus sativus extracts give protection 
against liver injury up on CCl4 induction more than the extracts of 
Lepidium sativum which may be due to the presence of saponins on 
Raphanus sativus. On the other hand Properties of Raphanus sativus 
extracts may interfere with free radical formation, also the antioxidant 
may supposed to be responsible for its hepatoprotective effect. 
 The elevated levels of serum enzymes are indicative of cellular 
leakage and loss of functional integrity cell membrane in liver 
(Zimmerman and Seef, 1970). 
 Histopathological changes such as necrosis, fatty change, 
ballooning, degeneration and inflammatory infiltration of lymphocytes 
around the central veins occurred in rats exposed to CCl4 0.2ml/kg 
(Valcheva et al, 2004; Ozbex, H. et al, 2004). These changes were similar 
to the present study. The simultaneous release of liver specific enzymes 
and bilirubin in the serum are evident by liver cell damage as apparent 
with structural changes in liver. 
 The results of this study indicate that the liver damage produced by 
CCl4 administration was found to be inhibited by methanolic and water 
extracts of Raphanus sativus with evidence of decrease levels in activities 
of serum aspartateaminotransferase (AST), alanineaminotransferase 
(ALT), alkaline phosphatase (AP) and bilirubin. These biochemical 
observations were supported by histopathological examination of liver. 
However the methanolic extract of Raphanus sativus was more potent 
than water extract, especially at dose 400 mg/kg. This may be due  
decreased absorption of Raphanus sativus in the water extract.   
The histopathological studies also provided supportive evidence for 
the plant hepatoprotective, as the hepatic cells are in a state of accelerated 
regeneration. 
 The rats received methanolic extract at dose 200 mg/kg of 
Lepidium sativum, AST and ALT were reduced while those received the 
dose 400 mg/kg were increased. The ethanolic extract administrated at 
dose 200 mg/kg and 400 mg/kg, only ALT and AP were  reduced. This 
result suggested that Lepidium sativum have mild hepatoprotective effect. 
This is supported by histopathological examination of the livers which 
showed moderate vaculation and congestion. 
 Some plants are found to have hepatoprotective activity due to 
presence of antioxidants such as flavonoid, triterpenoid, tannin and 
steroid nature (Banskota et al, 2000 ; Takeoka and Dao, 2003; DeFeudis 
et al, 2003). Raphanus sativus and Lepidium sativum contains tannins, 
flavonoid, triterpenoid, alkaloids and cumarins which may act as 
antioxidant principle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
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Recommendations 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION AND RECOMMENDATIONS 
 
 
 The clinical signs observed, coupled with the extract inhibitory 
effect on CCL4-induced hepatotoxicity and the clinical examination of 
the liver, indicated the significant hepatoprotective effect of the plant 
Raphanus sativus. Moreover the sub chronic toxicity results showed the 
safety of the studied extracts of the plant.  
Based on the above mention finding the present study suggests the 
following:- 
1- further biologically-guided fractionation of the most 
active extract to identify exactly the chemical nature of 
the active ingredients. 
2- In-detail pharmacological investigations of the active 
components of the extract. 
3- Acute and chronic toxicity studies. 
4- Standardization, and formulation of the acceptable 
dosage form. 
5- Clinical trials. 
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